February 19, 2017 6:58 AM ET

Biotechnology

Company Overview of Archemix Corp.

Key Executives for Archemix Corp.

NameBoard RelationshipsTitleAge
There is no Key Executives data available.

Archemix Corp. Board Members*

NameBoard RelationshipsPrimary CompanyAge
George H. Poste D.V.M., Ph.D., F.R.C. Path, F.R.S. 141 RelationshipsHealth Technology Networks72
Lawrence C. Best 20 RelationshipsOXO Capital LLC67
Michael J. Ross Ph.D. 127 RelationshipsSV Life Sciences Advisers, LLC67
Corey M. Mulloy 76 RelationshipsHighland Capital Partners45
Lawrence M. Gold Ph.D. 32 RelationshipsSomaLogic, Inc.74
View All Board Members

Archemix Corp. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Lawrence C. Best20 Relationships3 Executives
Advisory Board D.V.M., Ph.D., F.R.C. Path, F.R.S.George H. Poste141 Relationships5 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
355.2K
Bonus
240.7K
Total Short Term Compensation
445.1K
Total Value of Options
19.5M
Compensation as of Fiscal Year
Archemix Corp. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Kadmon Holdings Appoints Tasos G. Konidaris to Board of Directors
February 17, 2017 9:11 PM ET
Conatus Pharmaceuticals Inc. Announces Resignation of Charles J. Cashion as Senior Vice President, Finance, Chief Financial Officer and Secretary Effective from March 31, 2017
February 17, 2017 9:05 PM ET
Arvinas LLC Announces New Preclinical Data on Oral Androgen Receptor PROTAC at ASCO 2017 Genitourinary Cancers Symposium
February 17, 2017 5:15 PM ET
Catabasis Pharmaceuticals, Inc. Announces Promotion of Ted Hibben to Chief Business Officer
February 17, 2017 1:00 PM ET
Botanix Pharmaceuticals Limited Announces Executive Changes
February 17, 2017 1:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Archemix Corp., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.